Omeros Corporation
OMER
#6978
Rank
โ‚น63.94 B
Marketcap
โ‚น883.46
Share price
-1.38%
Change (1 day)
235.91%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -โ‚น10.33 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น15.04 Billion a decrease over its 2023 earnings that were of -โ‚น13.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.33 Billion-31.35%
2024 -โ‚น15.04 Billion9.63%
2023 -โ‚น13.72 Billion-9.57%
2022 -โ‚น15.17 Billion-30.65%
2021 -โ‚น21.87 Billion86.28%
2020 -โ‚น11.75 Billion99.45%
2019 -โ‚น5.89 Billion-49.91%
2018 -โ‚น11.76 Billion190.77%
2017 -โ‚น4.05 Billion-27.96%
2016 -โ‚น5.61 Billion-17.61%
2015 -โ‚น6.81 Billion1.88%
2014 -โ‚น6.69 Billion87.56%
2013 -โ‚น3.57 Billion
2011 -โ‚น2.61 Billion-8.96%
2010 -โ‚น2.87 Billion45.03%
2009 -โ‚น1.98 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.473 T-21,832.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.008 T-8,959.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚น0.37 Billion-96.77%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-โ‚น0.91 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA